Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Brighthouse Financial
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Aging Population And Digital Transformation Will Expand Market Opportunities
Key Takeaways Strong demand for annuities and innovative retirement products, plus expanded distribution, is broadening Brighthouse's customer base and supporting premium growth. Strategic focus on capital efficiency, technology investment, and a favorable interest rate environment is driving improved margins, operational leverage, and earnings stability.
View narrative
US$56.22
FV
18.0% undervalued
intrinsic discount
6.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Ballard Power Systems
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Overvaluation And Policy Tailwinds Will Reshape Hydrogen Mobility
Key Takeaways Investor optimism about hydrogen adoption and policy support may be overstating revenue growth prospects amid uneven market development and delayed large-scale orders. Anticipated margin and earnings improvements rely on unproven cost initiatives, while execution risks and competitive threats could undermine the company's long-term profitability.
View narrative
CA$1.62
FV
65.7% overvalued
intrinsic discount
30.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
26
users have followed this narrative
Updated
narrative
Quanterix
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Biomarker Diagnostics And Proteomics Will Shape Future Markets
Key Takeaways Integration with Akoya and expanded platform offerings are broadening market reach, increasing recurring revenue, and supporting sustainable, long-term growth with an improved cost structure. Major investments in technology and compatibility are positioning Quanterix to benefit from rising global demand for advanced biomarker diagnostics and early detection solutions.
View narrative
US$6.00
FV
16.2% undervalued
intrinsic discount
20.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
VerifyMe
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Freight Integration And Digital Advances Will Expand Global Markets
Key Takeaways Integration with major freight carriers and expanded e-commerce technology partnerships strengthen customer reach and position VerifyMe for growth in supply chain authentication solutions. Streamlined operations, strong cash reserves, and rising regulatory demand enhance profitability and create opportunities for strategic investment and long-term revenue growth.
View narrative
US$1.50
FV
40.8% undervalued
intrinsic discount
-2.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
EyePoint Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Phase III Trials In Wet AMD Will Expand Market Reach
Key Takeaways Successful late-stage trials and a durable eye disease treatment position the company for strong physician adoption and significant revenue growth upon approval. Strategic expansion, robust manufacturing, and disciplined financial management lower risk and enable long-term pipeline and market opportunity development.
View narrative
US$34.42
FV
67.9% undervalued
intrinsic discount
41.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
UroGen Pharma
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Office-Based Urology Therapies And Demographic Trends Will Redefine Care
Key Takeaways Successful ZUSDURI launch and pipeline expansion position UroGen for significant revenue growth and reduced product dependency. Alignment with industry care trends and robust commercialization strategy support premium pricing and improved long-term profitability.
View narrative
US$31.43
FV
39.8% undervalued
intrinsic discount
70.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
Updated
narrative
Root
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Next-generation AI Models Will Advance Insurance Yet Face Regulatory Hurdles
Key Takeaways Rapid deployment of advanced AI pricing and data-driven marketing is improving risk segmentation, customer value, and long-term margin potential. Expanding partnerships and new market entries are increasing policyholder growth and supporting sustainable revenue acceleration.
View narrative
US$137.60
FV
36.9% undervalued
intrinsic discount
11.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
Updated
narrative
Longeveron
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
FDA Alignment And HLHS Trial Will Enable Market Access
Key Takeaways Progress towards regulatory approval and commercialization for a lead therapy could significantly boost revenue and move the company closer to profitability. Expansion into new rare disease markets and innovative technologies supports long-term growth and reduces reliance on a single product.
View narrative
US$8.39
FV
90.1% undervalued
intrinsic discount
190.06%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
Updated
narrative
Viavi Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Data Center Upgrades And Fiber Demand Will Unlock Future Opportunities
Key Takeaways Strong demand for advanced optical and fiber solutions, driven by data center and fiber network upgrades, is propelling long-term structural revenue growth. Diversification into aerospace and defense plus increasing recurring revenue are reducing dependence on volatile markets and stabilizing earnings.
View narrative
US$13.41
FV
20.5% undervalued
intrinsic discount
6.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies